KUALA LUMPUR, May 11 (Bernama) -- Malaysia is cementing its position as Asia’s clinical research hub as Clinical Research Malaysia (CRM) launched CRM Trial Connect 2026, drawing more than 1,100 participants from across the global healthcare, regulatory and research ecosystem.
With the theme “Asia’s Rise in Clinical Trials,” the fifth edition of CRM Trial Connect showcases the region’s growing influence in global drug development. Last year’s event sparked more than 60 collaborations, generating RM70 million in value and advancing clinical research across Asia.
Health Minister Datuk Seri Dr Dzulkefly Ahmad, who officiated the conference, underscored the platform’s role in fostering alignment, partnership, and growth. He reaffirmed Malaysia’s commitment to strengthening the region’s position through continued advancement in clinical research.
“This conference reflects not only how far we have come, but also the direction we must take together as we shape the future of clinical research in Southeast Asia and across Asia,” he said in his keynote address.
During the ceremony, the Minister also launched the latest edition of Malaysia’s Good Clinical Practice Guidelines, reinforcing the nation’s commitment to upholding international standards and ensuring the highest quality in clinical trial conduct.
Other program highlights included:
- Global partnerships: Memorandum of Understanding between CRM and Monash Health, Australia, and Research Agreement with Japan’s National Cancer Center under the ATLAS (Asia Clinical Trials Network for Cancers) project.
- Recognition: Presentation of the CRM Sponsored Research Awards 2026, honouring outstanding contributions by investigators, study sites, research organisations, and sponsors.
- International collaboration: Participation from agencies such as Japan’s PMDA, ARISE, and IA-DATA, reinforcing the importance of global networks in advancing clinical research.
- Expert insights: Contributions from leading voices including Dr Timothy Yap (MD Anderson Cancer Center), Professor Jacob George (UK MHRA), and Dr Yasuhiro Fujiwara (PMDA), covering translational medicine, clinical innovation, and regulatory science.
- Collaborating event: The conference also featured the 18th National Conference for Clinical Research, further strengthening Malaysia’s role in uniting the clinical research community.
Marking five years of impact, CRM Trial Connect has become a premier regional platform for strategic engagement, offering symposium sessions, panel discussions, and networking opportunities that strengthen Asia’s role in shaping the future of clinical trials.
SOURCE: Clinical Research Malaysia (CRM)
FOR MORE INFORMATION, PLEASE CONTACT:
Name: Sufea Salehuddin
Corporate Communications Executive
Tel: +6011-11202702 | +603-7931 5566 (ext. 125)
Email: sufea.irdina@clinicalresearch.my
--BERNAMA 
